secwatch / observer
8-K filed July 29, 2024, 7:59 PM ET ticker PTHS CIK 0001919246
other material confidence high sentiment negative materiality 0.80

Chromocell raises $750k via convertible note and secures $30M committed equity facility

Pelthos Therapeutics Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001753926-24-001275
form_type
8-K
ticker
PTHS
cik
0001919246
company_name
Pelthos Therapeutics Inc.
filed_at
2024-07-29T23:59:59+00:00
discovered_at
2026-05-14T18:03:15.198093+00:00
generated_at
2026-05-31T15:48:01.033935+00:00
sec_items
["1.01", "2.03", "3.02", "7.01", "8.01", "9.01"]
event_type
other_material
sentiment
negative
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001753926-24-001275
json_url
https://secwatch.observer/filing/0001753926-24-001275.json
markdown_url
https://secwatch.observer/filing/0001753926-24-001275.md
text_url
https://secwatch.observer/filing/0001753926-24-001275.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1919246/000175392624001275/0001753926-24-001275-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1919246/000175392624001275/g084348_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 1.01, 2.03, 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

OPTU

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 1.01, 3.02, 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 1.01, 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ZSPC

zSpace restructures $12M debt via equity conversion; creates Series P-2 preferred

zSpace, Inc. June 1, 2026, 8:00 AM ET other_material Items 1.01, 1.02, 2.03, 3.02, 5.03, 9.01

same SEC item: 1.01, 2.03, 3.02, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AIRJ

AirJoule Technologies raises $15M in registered direct offering at $4.10/share

AirJoule Technologies Corp. June 1, 2026, 8:34 AM ET other_material Items 1.01, 5.07, 7.01, 9.01

same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001753926-24-001275

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.